Item Type | Name |
Concept
|
Radiotherapy, Computer-Assisted
|
Concept
|
Radiotherapy
|
Concept
|
Radiotherapy Planning, Computer-Assisted
|
Concept
|
Radiotherapy, Intensity-Modulated
|
Concept
|
Radiotherapy, Conformal
|
Concept
|
Radiotherapy Dosage
|
Concept
|
Radiotherapy, High-Energy
|
Concept
|
Radiotherapy, Image-Guided
|
Concept
|
Radiotherapy, Adjuvant
|
Academic Article
|
Treatment and prognosis of orbital non-Hodgkin's lymphomas.
|
Academic Article
|
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.
|
Academic Article
|
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
|
Academic Article
|
Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis.
|
Academic Article
|
Radiation oncology.
|
Academic Article
|
Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
|
Academic Article
|
DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapy.
|
Academic Article
|
Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer.
|
Academic Article
|
Growth factors alter the therapeutic ratio in radiotherapy.
|
Academic Article
|
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
|
Academic Article
|
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
|
Academic Article
|
Functional imaging in treatment planning of brain lesions.
|
Academic Article
|
Increased injection number enhances adenoviral genetic radiotherapy.
|
Academic Article
|
Radiogenetic therapy: on the interaction of viral therapy and ionizing radiation for improving local control of tumors.
|
Academic Article
|
Role of gene therapy in radiation oncology.
|
Academic Article
|
Temporal bone chemodectomas--comparing surgery and radiation therapy.
|
Academic Article
|
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
|
Academic Article
|
Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors.
|
Academic Article
|
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.
|
Academic Article
|
Volumetric visualization of head and neck CT data for treatment planning.
|
Academic Article
|
Molecular targeting of gene therapy and radiotherapy.
|
Academic Article
|
Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
|
Academic Article
|
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
|
Academic Article
|
PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after intervention.
|
Academic Article
|
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
|
Academic Article
|
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.
|
Academic Article
|
Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience.
|
Academic Article
|
Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors.
|
Academic Article
|
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
|
Academic Article
|
Palliative radiotherapy.
|
Academic Article
|
Evolution of toxicity after conformal radiotherapy for prostate cancer.
|
Academic Article
|
Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.
|
Academic Article
|
Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy.
|
Academic Article
|
Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy.
|
Academic Article
|
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
|
Academic Article
|
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy.
|
Academic Article
|
Influence of radioimmunoscintigraphy on postprostatectomy radiotherapy treatment decision making.
|
Academic Article
|
Radiotherapy with concomitant chemotherapy for head and neck cancer.
|
Academic Article
|
Radiation therapy: activation for gene transcription and the development of genetic radiotherapy-therapeutic strategies in oncology.
|
Academic Article
|
Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report).
|
Academic Article
|
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
|
Academic Article
|
Radiation's outer limits.
|
Academic Article
|
Possible applications of biotechnology to radiotherapy.
|
Academic Article
|
Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer.
|
Academic Article
|
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
|
Academic Article
|
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
|
Academic Article
|
Recent advances in radiation therapy for head and neck cancer.
|
Academic Article
|
Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters.
|
Academic Article
|
Relevance and irrelevance of DNA damage response to radiotherapy.
|
Academic Article
|
TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors.
|
Academic Article
|
Impact of radioimmunoscintigraphy on definition of clinical target volume for radiotherapy after prostatectomy.
|
Academic Article
|
Enhancing radiotherapy with genetically engineered viruses.
|
Academic Article
|
A rationale for the targeted treatment of oligometastases with radiotherapy.
|
Academic Article
|
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical control.
|
Academic Article
|
Fibroblast radiosensitivity and intraocular fibrovascular proliferation following radiotherapy for bilateral retinoblastoma.
|
Academic Article
|
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.
|
Academic Article
|
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study.
|
Academic Article
|
Importance of local control in an era of systemic therapy.
|
Academic Article
|
Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers.
|
Academic Article
|
Characterization of response to radiation mediated gene therapy by means of multimodality imaging.
|
Academic Article
|
Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores.
|
Academic Article
|
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.
|
Academic Article
|
Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy.
|
Academic Article
|
Breast conserving surgery and definitive irradiation for early stage breast cancer.
|
Academic Article
|
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
|
Academic Article
|
The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.
|
Academic Article
|
Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?
|
Academic Article
|
Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience.
|
Academic Article
|
Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy.
|
Academic Article
|
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?
|
Academic Article
|
Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy.
|
Academic Article
|
The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone.
|
Academic Article
|
Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas.
|
Academic Article
|
Issues of controversy in radiation therapy and combined modality approaches to Hodgkin's disease.
|
Academic Article
|
Concomitant hydroxyurea, 5-fluorouracil, and radiation therapy for recurrent head and neck cancer: early results.
|
Academic Article
|
Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy.
|
Academic Article
|
Palliation of hepatic metastasis.
|
Academic Article
|
Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease.
|
Academic Article
|
Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy.
|
Academic Article
|
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck.
|
Academic Article
|
Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
|
Academic Article
|
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
|
Academic Article
|
Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer.
|
Academic Article
|
An aggressive approach to marginally resectable lung cancer.
|
Academic Article
|
The role of radiotherapy in locally advanced pancreatic carcinoma.
|
Academic Article
|
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.
|
Academic Article
|
The maximum recovery potential of human tumor cells may predict clinical outcome in radiotherapy.
|
Academic Article
|
Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck.
|
Academic Article
|
Preliminary results of aggressive multimodality therapy for metastatic osteosarcoma.
|
Academic Article
|
Superficial doses in treatment of breast with tangential fields using 4MV x-rays.
|
Academic Article
|
Repair of potentially lethal X ray damage and possible applications to clinical radiotherapy.
|
Academic Article
|
Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma.
|
Academic Article
|
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
|
Academic Article
|
Radiation therapy in the management of patients with mesothelioma.
|
Academic Article
|
The role of DNA repair processes in the response of human tumors to fractionated radiotherapy.
|
Academic Article
|
Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancer.
|
Academic Article
|
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
|
Academic Article
|
Development of additional primary tumors after 62 years in the first patient with retinoblastoma cured by radiation therapy.
|
Academic Article
|
Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery.
|
Academic Article
|
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
|
Academic Article
|
The role of paclitaxel in the treatment of head and neck cancer.
|
Academic Article
|
The significance of positive chorionic gonadotropins in apparently pure seminoma of the testis.
|
Academic Article
|
Twice-a-day fractionation preoperative radiotherapy in patients with carcinoma of the bladder: preliminary report.
|
Academic Article
|
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results.
|
Academic Article
|
Combination hormonal, chemotherapy and radiotherapy in vitro: implications for therapy in vivo.
|
Academic Article
|
Radiation oncology.
|
Academic Article
|
The role of radiation therapy in the treatment of soft tissue sarcomas of childhood.
|
Academic Article
|
Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer.
|
Academic Article
|
Characterization of the theorectical radiation dose enhancement from nanoparticles.
|
Academic Article
|
Radiation therapy in head and neck cancer: indications and limitations.
|
Academic Article
|
Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapy.
|
Academic Article
|
The characteristics of long-term survivors of lung cancer treated with radiation.
|
Academic Article
|
Fraction size and the repair of potentially lethal radiation damage in a human melanoma cell line. Possible implications for radiotherapy.
|
Academic Article
|
Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience.
|
Academic Article
|
Radiotherapy of the resected mandible following stainless steel plate fixation.
|
Academic Article
|
Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.
|
Academic Article
|
Glioblastoma cells block radiation-induced programmed cell death of endothelial cells.
|
Academic Article
|
Monosomy 12p in a radiation-induced germ cell tumor.
|
Academic Article
|
gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy.
|
Academic Article
|
Estimates of dose to intraperitoneal micrometastases from alpha and beta emitters in radioimmunotherapy.
|
Academic Article
|
Outcomes in black patients with early breast cancer treated with breast conservation therapy.
|
Academic Article
|
Radiation therapy for non-Hodgkin's lymphoma.
|
Academic Article
|
The confluence of radiotherapy and immunotherapy.
|
Academic Article
|
The role of post-operative radiation therapy in the treatment of malignant tumors of the parotid gland.
|
Academic Article
|
Radiation therapy in the treatment of aggressive fibromatoses.
|
Academic Article
|
The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy.
|
Academic Article
|
Measurement of weekly prostate specific antigen levels in patients receiving pelvic radiotherapy for nonprostatic malignancies.
|
Academic Article
|
Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.
|
Academic Article
|
Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
|
Academic Article
|
Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.
|
Academic Article
|
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
|
Academic Article
|
A survivin-associated adaptive response in radiation therapy.
|
Academic Article
|
Stereotactic body radiation therapy for curative treatment of adrenal metastases.
|
Academic Article
|
The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study.
|
Academic Article
|
Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy.
|
Academic Article
|
The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy.
|
Academic Article
|
Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
|
Academic Article
|
Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs.
|
Academic Article
|
Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
|
Academic Article
|
EPR oxygen images predict tumor control by a 50% tumor control radiation dose.
|
Academic Article
|
Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease.
|
Academic Article
|
Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers.
|
Academic Article
|
Stereotactic radiotherapy for pulmonary metastases.
|
Academic Article
|
Racial parities in outcomes after radiotherapy for head and neck cancer.
|
Academic Article
|
Radiotherapy and immune checkpoint blockade: potential interactions and future directions.
|
Academic Article
|
Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer.
|
Academic Article
|
From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy.
|
Academic Article
|
Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.
|
Academic Article
|
Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?
|
Academic Article
|
Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT).
|
Academic Article
|
Autologous Bone Marrow Transplantation Followed by Involved Field Radiotherapy in Patients with Relapsed or Refractory Hodgkin's Disease.
|
Academic Article
|
Image-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment.
|
Academic Article
|
Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance.
|
Academic Article
|
Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.
|
Academic Article
|
The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications.
|
Academic Article
|
Radiotherapy and immunotherapy: a beneficial liaison?
|
Academic Article
|
Differences in Survival With Surgery and Postoperative Radiotherapy Compared With Definitive Chemoradiotherapy for Oral Cavity Cancer: A National Cancer Database Analysis.
|
Academic Article
|
Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.
|
Academic Article
|
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.
|
Academic Article
|
Oxygen-Guided Radiation Therapy.
|
Academic Article
|
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy.
|
Academic Article
|
Rhythmic radiotherapy beats down TGF-ß.
|
Academic Article
|
Rhythmic radiotherapy beats down TGF-ß.
|
Academic Article
|
Non-canonical NF-?B Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy.
|
Academic Article
|
Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
|
Academic Article
|
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
|
Academic Article
|
Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities.
|
Academic Article
|
Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
|
Academic Article
|
Integration of radiotherapy and immunotherapy for treatment of oligometastases.
|
Academic Article
|
Tumor-reprogrammed resident T cells resist radiation to control tumors.
|
Academic Article
|
Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite".
|
Academic Article
|
Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research.
|
Academic Article
|
Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable.
|
Academic Article
|
Is It Worth It? Consequences of Definitive Head and Neck Reirradiation.
|
Academic Article
|
Response Letter: Radiation therapy for COVID-19 pneumopathy.
|
Academic Article
|
Coronavirus Disease 2019 Infection Prevention and Control Practices in Wuhan Radiation Therapy.
|
Academic Article
|
Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation Therapy.
|
Academic Article
|
Ultrathin metal-organic layer-mediated radiotherapy-radiodynamic therapy enhances immunotherapy of metastatic cancers.
|
Academic Article
|
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial.
|
Academic Article
|
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
|
Academic Article
|
RIG-I-Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy.
|
Academic Article
|
The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes.
|
Academic Article
|
Small Animal IMRT Using 3D-Printed Compensators.
|
Academic Article
|
Drug-Radiotherapy Combination Trial Developments-Response.
|
Academic Article
|
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity.
|
Academic Article
|
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future Focus.
|
Academic Article
|
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors.
|
Academic Article
|
Prospective Clinical Investigation of the Efficacy of Combination Radiation Therapy With Immune Checkpoint Inhibition.
|
Academic Article
|
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study.
|
Academic Article
|
Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy-Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression.
|
Academic Article
|
Evaluation of Initial Metastatic Tumor Location and Radiation Response to Determine Outcomes in Patients Who Received Combination Stereotactic Body Radiotherapy and Immunotherapy for NSCLC.
|
Academic Article
|
Radiotherapy and immunotherapy: open questions and future strategies.
|
Academic Article
|
Immunotherapy for the Neoadjuvant Management of Resectable Intrathoracic Cancers: Let's Not Forget Radiotherapy.
|
Academic Article
|
Synergistic checkpoint-blockade and radiotherapy-radiodynamic therapy via an immunomodulatory nanoscale metal-organic framework.
|
Academic Article
|
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy.
|
Academic Article
|
Dimethylaminomicheliolide Sensitizes Cancer Cells to Radiotherapy for Synergistic Combination with Immune Checkpoint Blockade.
|
Academic Article
|
Author Correction: Synergistic checkpoint-blockade and radiotherapy-radiodynamic therapy via an immunomodulatory nanoscale metal-organic framework.
|
Academic Article
|
Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy.
|
Academic Article
|
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
|
Academic Article
|
YTHDF2 inhibition potentiates radiotherapy antitumor efficacy.
|
Academic Article
|
Nanoscale Metal-Organic Framework with an X-ray Triggerable Prodrug for Synergistic Radiotherapy and Chemotherapy.
|
Academic Article
|
Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models.
|
Academic Article
|
Corrigendum: Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models.
|
Academic Article
|
RNA m6A methylation and MDSCs: Roles and therapeutic implications for radiotherapy.
|
Academic Article
|
Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites.
|
Academic Article
|
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal.
|
Academic Article
|
Radiotherapy and immunology.
|
Academic Article
|
Radiotherapy, immunity, and immune checkpoint inhibitors.
|
Academic Article
|
Digitonin-Loaded Nanoscale Metal-Organic Framework for Mitochondria-Targeted Radiotherapy-Radiodynamic Therapy and Disulfidptosis.
|
Academic Article
|
Bifunctional Metal-Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio-Immunotherapy.
|